Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01334944 · ClinicalTrials.gov registry record · Phase 4

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

A Phase 4 study of Pain and Fever, sponsored by Cumberland Pharmaceuticals.

Completed
Registry status
Phase 4
Development phase
150
Enrollment target
13
Study locations

NCT01334944 is a Phase 4 study of Pain and Fever that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 150 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (51% lower). The trial reports 13 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01334944, a Phase 4 study of Pain and Fever, has completed, sponsored by Cumberland Pharmaceuticals.

COMPLETED
Registry status
Phase 4
Development phase
150 participants
Enrollment target
13
Study locations

Study Summary

The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.

Conditions Studied

Pain Fever

Interventions

  • DRUG Intravenous ibuprofen

Study Locations (13)

North Carolina

  • The University of North Carolina Hospitals - Chapel Hill
  • Duke University Medical Center - Durham
  • The Moses H. Cone Memorial Hospital - Greensboro
  • Wake Forest University Baptist Medical Center - Winston-Salem

Ohio

  • Fairview - Cleveland
  • The Ohio State University Medical Center - Columbus

California

  • UCSD - San Diego

Connecticut

  • Danbury - Danbury

Florida

  • University of Miami - Miller School of Medicine - Miami

Georgia

  • Grady - Atlanta

Massachusetts

  • Beth Israel Deaconnes MC - Boston

New York

  • Columbia - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2011-06
Est. Completion 2012-10
Phase Phase 4

Sponsor

Cumberland Pharmaceuticals

43 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01334944

The ClinicalTrials.gov registry entry for NCT01334944 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (51% lower). The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Intravenous ibuprofen is the first listed.

NCT01334944 reports 13 study locations spanning 9 distinct geographic areas - top geographies include North Carolina, Ohio, California.

Frequently Asked Questions

What is clinical trial NCT01334944 about?

NCT01334944 is a clinical study titled "Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen". The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.

What is the current status of trial NCT01334944?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2011-06. Estimated completion is 2012-10.

What conditions does trial NCT01334944 study?

This clinical trial studies the following conditions: Pain, Fever.

What interventions are being tested in trial NCT01334944?

The interventions under investigation include: Intravenous ibuprofen (DRUG).

Who is sponsoring clinical trial NCT01334944?

This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01334944 being conducted?

This trial has 13 study locations across California, Connecticut, Florida, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Fever

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.